Pinnacle Wealth Planning Services’s Legend Biotech LEGN Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.42K	Buy	+410	New	+$7.82K	﹤0.01%	2128

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FBIL

First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Pinnacle Wealth Planning Services's LEGN Position: Q1 2026 in Review

Pinnacle Wealth Planning Services opened a new position in Legend Biotech (LEGN) in Q1 2026: 410 shares worth $7.42K. The stake represents ﹤0.01% of the portfolio and ranks #2128 among its holdings.

189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

Pinnacle Wealth Planning Services held 410 shares of Legend Biotech worth $7.42K as of Q1 2026.
Legend Biotech was a new Pinnacle Wealth Planning Services position in Q1 2026.
Legend Biotech made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q1 2026, its #2128 holding.
189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q1 2026, filed 11 May 2026.